Trial Details

Not Recruiting
Basic Information
Clinical ID c2988
Identifier EUCTR2015-001942-28-CZ
Trial Title A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of APD334 in Patients with Moderately to Severely Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Ulcerative colitis MedDRA version: 19.0_Level: LLT_Classification code 10045365_Term: Ulcerative colitis_System Organ Class: 100000004856_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Product Code: APD334 Pharmaceutical Form: Capsule, hard INN or Proposed INN: Not yet available Current Sponsor code: APD334 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 1- Pharmaceutical form of the placebo: Capsule, hard Route of administration of the placebo: Oral use Product Code: APD334 Pharmaceutical Form: Capsule, hard INN or Proposed INN: Not yet available Current Sponsor code: APD334 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 2- Pharmaceutical form of the placebo: Capsule, hard Route of administration of the placebo: Oral use
Participant Information
Sponsor Arena Pharmaceuticals, Inc.
City -
Country/Region United States;Spain;Ukraine;Lithuania;Austria;Israel;United Kingdom;France;Czech Republic;Hungary;Canada;Poland;Belgium;Romania;Australia;Bulgaria;Latvia;Germany;New Zealand
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -